Onyx Pharmaceuticals was a biopharmaceutical company focused on developing and marketing medicines for the treatment of cancer. Founded in 1992, it was later acquired by Amgen and became a subsidiary. The company was known for its innovative cancer therapies.
Focus Areas
Notable Investments
